Nuvectis Pharma, Inc.
Rachunek Zysków i Strat
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
Rok finansowy |
2021 |
2021 |
2021 |
2021 |
2022 |
2022 |
2022 |
2022 |
2023 |
2023 |
2023 |
2023 |
2024 |
2024 |
2024 |
2024 |
2025 |
Kwartał |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Data |
2021-03-31 |
2021-06-30 |
2021-09-30 |
2021-12-31 |
2022-03-31 |
2022-06-30 |
2022-09-30 |
2022-12-31 |
2023-03-31 |
2023-06-30 |
2023-09-30 |
2023-12-31 |
2024-03-31 |
2024-06-30 |
2024-09-30 |
2024-12-31 |
2025-03-31 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4 |
0 |
0 |
-4 |
0 |
0 |
0 |
0 |
0 |
Przychód Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
3625.0% |
inf% |
0.0% |
0.0% |
-2852.35% |
-100.00% |
0.0% |
0.0% |
-100.00% |
0.0% |
Marża brutto |
0.0% |
0.0% |
0.0% |
100.0% |
-inf% |
-inf% |
0.0% |
100.0% |
100.0% |
-inf% |
-inf% |
367.4% |
-inf% |
-inf% |
-inf% |
0.0% |
0.0% |
Koszty i Wydatki (mln) |
0 |
6 |
5 |
2 |
3 |
4 |
6 |
7 |
4 |
6 |
6 |
7 |
4 |
5 |
4 |
6 |
6 |
EBIT (mln) |
-0 |
-6 |
-5 |
-2 |
-3 |
-4 |
-6 |
-7 |
-4 |
-6 |
-6 |
-7 |
-4 |
-5 |
-4 |
-6 |
-6 |
EBIT Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
12687.0% |
-39.83% |
27.2% |
199.2% |
39.4% |
61.5% |
3.7% |
1.3% |
7.2% |
-19.56% |
-29.21% |
-6.07% |
26.7% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
-56625.00% |
0.0% |
0.0% |
0.0% |
-4548.99% |
-100.00% |
0.0% |
0.0% |
167.4% |
0.0% |
0.0% |
0.0% |
nan |
nan |
Przychody fiansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Amortyzacja (mln) |
0 |
6 |
5 |
-7 |
-0 |
0 |
0 |
-1 |
4 |
0 |
-0 |
-1 |
0 |
0 |
0 |
0 |
0 |
EBITDA (mln) |
-0 |
-6 |
-5 |
-2 |
-3 |
-4 |
-6 |
-7 |
0 |
-6 |
-6 |
-7 |
-4 |
-5 |
-4 |
-6 |
-6 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
-56625.00% |
0.0% |
0.0% |
0.0% |
-4548.99% |
-100.00% |
0.0% |
0.0% |
167.4% |
0.0% |
0.0% |
0.0% |
nan |
nan |
NOPLAT (mln) |
-0 |
-6 |
-5 |
-2 |
-3 |
-4 |
-6 |
-7 |
-4 |
-6 |
-6 |
-7 |
-4 |
-4 |
-4 |
-6 |
-5 |
Podatek (mln) |
-0 |
-6 |
-5 |
-0 |
-0 |
-0 |
0 |
-0 |
-0 |
6 |
6 |
0 |
-0 |
0 |
0 |
0 |
0 |
Zysk Netto (mln) |
-0 |
-6 |
-5 |
-2 |
-3 |
-4 |
-6 |
-7 |
-4 |
-6 |
-6 |
-7 |
-4 |
-4 |
-4 |
-6 |
-5 |
Zysk netto Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
12678.3% |
-40.03% |
25.9% |
188.9% |
36.0% |
60.3% |
0.1% |
1.4% |
4.4% |
-22.42% |
-29.38% |
-5.65% |
27.8% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
-56525.00% |
0.0% |
0.0% |
0.0% |
-4383.89% |
-97.46% |
0.0% |
0.0% |
161.5% |
0.0% |
0.0% |
0.0% |
nan |
nan |
EPS |
-0.0018 |
-0.47 |
-0.39 |
-0.18 |
-0.32 |
-0.28 |
-0.42 |
-0.45 |
-0.27 |
-0.38 |
-0.37 |
-0.38 |
-0.25 |
-0.26 |
-0.24 |
-0.37 |
-0.27 |
EPS (rozwodnione) |
-0.0018 |
-0.47 |
-0.39 |
-0.18 |
-0.32 |
-0.28 |
-0.42 |
-0.45 |
-0.27 |
-0.38 |
-0.37 |
-0.38 |
-0.25 |
-0.26 |
-0.24 |
-0.37 |
-0.27 |
Ilośc akcji (mln) |
13 |
13 |
12 |
13 |
9 |
13 |
14 |
15 |
15 |
15 |
16 |
17 |
17 |
17 |
17 |
17 |
20 |
Ważona ilośc akcji (mln) |
13 |
13 |
12 |
13 |
9 |
13 |
14 |
15 |
15 |
15 |
16 |
17 |
17 |
17 |
17 |
17 |
20 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |